Skip to content

Cardiovascular Risk in General Practice in France: Cardiovascular Risk Week

Cardiovascular Risk in General Practice in France

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01308372
Enrollment
9246
Registered
2011-03-04
Start date
2011-10-31
Completion date
2011-10-31
Last updated
2011-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

cardiovascular risk, France, General practice, Primary prevention, Non treated patients

Brief summary

The purpose of this study is to evaluate the proportion of patients which present a high cardiovascular risk estimated by the SCORE scale, in general practice consultations of the 7 French regions (Paris area, North-East, Paris basin, West, South-West, South- East, Mediterranean area)

Detailed description

MC MD

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Without any personal history of coronary disease * Non treated with lipid-lowering agents * Lipid test = 1 year old * Presenting at least one cardiovascular risk * Visiting their General Practitioner

Design outcomes

Primary

MeasureTime frame
Evaluation of cardiovascular risk in general practice in France estimated by the SCORE scale1 week

Secondary

MeasureTime frame
Evaluation of arteries age evaluation by SCORE1 week
Evaluation of cardiovascular risk in general practice in France estimated by the Framingham 2008 scale D'Agostino1 week
Evaluation of cardiovascular risk in general practice in France estimated by the Framingham 1998 scale Wilson1 week

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026